Previous Close | 2.3600 |
Open | 2.3600 |
Bid | 2.3600 x N/A |
Ask | 2.4700 x N/A |
Day's Range | 2.2500 - 2.4700 |
52 Week Range | 2.0300 - 4.4400 |
Volume | |
Avg. Volume | 4,917 |
Market Cap | 16.711M |
Beta (5Y Monthly) | 1.88 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4900 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for NXTMH.HE
Company announcement, Helsinki, 30 November 2023 at 10 AM (EET) Nexstim Plc Changes Certified Advisor to Carnegie Investment Bank AB (publ) Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") today announces a change of Certified Adviser from Erik Penser Bank AB to Carnegie Investment Bank AB (publ). Nexstim has entered into an agreement with Carnegie Investment Bank AB (publ) regarding the position as Certified Adviser. Carnegie Investment Bank AB (publ) will take over as Certified Adviser on Nove
Press release, Helsinki, 20 November 2023 at 11 AM (EET) Nexstim Receives NBS System 6 Order from Hospital in United States Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) announces having received an NBS System 6 order from a hospital in Massachusetts, United States. Nexstim released the NBS 6 in the spring of 2023 and announced first order for the system on November 14. The NBS System 6 is a new generation system that makes Nexstim’s established TMS technology even more intuitive to use and a
Press release, Helsinki, 14 November 2023, at 12:30 PM (EET) Nexstim Receives First Order for NBS 6 Therapy System in the United States Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) announces that its’ US subsidiary, Nexstim, Inc. has received the first order for a new NBS 6 therapy system. Nexstim will deliver the NBS System 6 and support services to a private clinic located in North Carolina, United States. The NBS 6 is a new generation Nexstim system that was released in the spring of 2023